Acthar Gel (repository corticotropin injection) for persistently active SLE: study design and baseline characteristics from a multicentre, randomised, double-blind, placebo-controlled trial

OBJECTIVE: SLE is a chronic inflammatory autoimmune disease characterised by the excessive production of autoantibodies, immune complexes and proinflammatory cytokines. Repository corticotropin injection (RCI) is a naturally sourced complex mixture of adrenocorticotropic hormone analogues and other...

Descripción completa

Detalles Bibliográficos
Autores principales: Askanase, Anca D, Zhao, Enxu, Zhu, Julie, Connolly-Strong, Erin, Furie, Richard A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7204552/
https://www.ncbi.nlm.nih.gov/pubmed/32399253
http://dx.doi.org/10.1136/lupus-2020-000383

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7204552/
https://www.ncbi.nlm.nih.gov/pubmed/32399253
http://dx.doi.org/10.1136/lupus-2020-000383

Ejemplares similares